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ABSTRACT
INTRODUCTION: Testicular cancer is the most common type 
of cancer in young Caucasian men. It has been suggested 
that testicular microlithiasis (TML) is a premalignant condi­
tion. This study’s objective was to investigate TML histology 
prevalence in testicular cancer patients in two European 
populations.
METHODS: We analysed archived histopathology orchiec­
tomy specimens from 152 patients diagnosed with testicu­
lar cancer at Fredericia Hospital in Denmark from 2004 to 
2014, and 106 patients diagnosed at St Thomas’ Hospital in 
London from 2011 to 2015.
RESULTS: The Danish patients’ median age was 37 years 
(range: 16­74 years) and the English patients’ 36 years 
(range: 18­78 years). In the Danish patients, 29 (19.1%) had 
TML, and in the English patients, 43 (40.6%) had TML (p < 
0.001). Haematoxylin bodies were slightly more common in 
the English patients. Laminated calcification was more often 
seen in seminomas than in non­seminomas.
CONCLUSIONS: The English testicular cancer patients had a 
statistically significantly higher TML prevalence than the 
Danish patients. This observation questions the hypoth­
esised biological association between TML and testicular  
cancer.  
FUNDING: The Region of Southern Denmark supported this 
study.
TRIAL REGISTRATION: not relevant.
Testicular cancer is the most common type of cancer in 
young Caucasian men. It has been suggested that tes­
ticular microlithiasis (TML) is a premalignant condition 
[1, 2], especially for seminoma [3, 4]. TML can be visual­
ised by ultrasonography or histopathology. TML does 
not cause pain or symptoms, and is impalpable. TML is a 
relatively common condition and is ultrasonically visual­
ised by small high­echogenic spots 1­3 mm in diameter, 
often spread throughout the parenchyma of the testis. 
TML is an incidental finding in scrotal ultrasound exam­
in ations. There are two main histopathological types of 
TML: laminated calcification (Figure 1A) and haematoxy­
lin bodies (Figure 1B) [5].  
There are different approaches to categorising TML, 
but the most used is a simple grading system with five or 
more microliths in the whole testis defined as classic 
TML, and limited TML if there are fewer than five micro­
liths per testis.
A number of retrospective ultrasound studies have 
investigated the prevalence of TML in patients with tes­
ticular tumours. Some studies have found a higher TML 
prevalence in patients with testicular tumour than in pa­
tients with no pathology. The reported TML prevalence 
in symptomatic populations without testicular tumours 
varies from 9% to 18% [6, 7], and the reported TML 
prevalence in patients with testicular tumours varies 
from 15 to 57% [8­11]. 
Our aim was to assess histopathological TML preva­
lence in patients with testicular cancer from two Euro­
pean populations, and to investigate the relationship be­
tween TML and cancer­histologic subtypes of testicular 
cancer.  
METHODS
A histopathological study investigating all testicular can­
cers from two hospitals in two European countries was 
performed. All the histopathology cancer specimens 
from Denmark were microscopically reviewed separ­
ately by MRP and JL (a senior pathologist with more 
than 15 years of experience). From England, all the his­
topathology cancer specimens were microscopically re­
viewed separately by MRP, OF and CH (a senior pathol­
ogist with more than 15 years of experience), 
Patients from Denmark
Included in the study were all patients diagnosed with 
testicular cancer and who had an orchiectomy per­
formed at Fredericia Hospital in the period from 2004 to 
2014. A patient could be eligible only once, i.e. if the 
contralateral testicle was diagnosed with cancer during 
2004 to 2014, the second cancer was not included. 
Three testicles were excluded due to bilateral cancer.  
A total of 152 patients were eligible.
All pathology reports were reviewed; however,  
TML is not routinely described in the pathology report­
ing from the Danish hospital and no information about 
TML was reported in the pathology reports. 
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Patients from England
Included were all patients diagnosed with testicular can­
cer and who had an orchiectomy performed at St Thom­
as’ Hospital, London from 2011 to 2015. We searched 
the hospital’s electronic pathology system (PathNet) and 
the hospital’s Electronic Patient Registry system and 
found a total of 106 patients with testicular cancer. 
None of the included 106 patients were diagnosed with 
bilateral cancer during the period from 2011 to 2015. 
All pathology reports were reviewed, but TML is not 
routinely described in pathology reporting and none of 
the reports included information about TML.
Ethics
In Denmark, the Danish Data Protection Agency and The 
Regional Scientific Ethical Committees for Southern Den­
mark (ID: S­20120144 – additional protocol 46175) ap­
proved this study. We searched the Danish Registry for 
Use of Tissue (Vævsanvendelsesregister) using the Dan­
ish Central Personal Registration Number [12]. Every citi­
zen in Denmark has a unique Central Personal Registra­
tion Number, which is linked to all medical records and 
official registries including the pathology register. In 
Denmark, patients have full control over his or her own 
biological material. To practice this right, the patient 
needs to register in The Registry for Use of Tissue. All 
health researchers are responsible for consulting The 
Registry for Use of Tissue before human biological mat­
erial can be used in research. None of the patients had 
chosen to opt out according to The Registry for Use of 
Tissue [13]. Trial registration was not relevant.
In England, this study was not defined as a research 
study according to the National Health Service and eth­
ics committee approval was therefore not necessary. 
Data 
Data were collected from the Electronic Patient Record 
Systems in the two hospitals: patient age at time of diag­
nosis, calendar year of diagnosis, ethnicity (White, Black, 
Asian, other specified ethnicities or unknown), tumour 
histology, tumour size and tumour stage. 
From the microscopic review of specimens, we  
collected data concerning TML status, total number of  
microliths in the specimens, tissue location of the micro­
liths, number of slides with TML and if any macro­cal ci­
fication was present. 
Statistical analysis 
We calculated prevalence odds ratios (OR) for TML in re­
lation to ethnicity, histology, age, right­ or left­sided tes­
ticular tumour and tumour size, using logistic regression. 
In the multivariable analysis, we calculated ORs adjusted 
for year of diagnosis and age. 
We calculated ORs with a 95% confidence interval 
(CI) using STATA statistical software (version 14.1, STATA 
corporation, College Station, TX, USA). 
Trial registration: not relevant.
RESULTS
The median age in the Danish patients was 37 years 
(range: 16­74 years) and in the English patients 36 years 
(range: 18­78 years). The mean tumour size was 45.0 
mm (range: 18.0­135.0 mm) in the Danish patients and 
31.0 mm (range: 9­70 mm) in the English patients. A to­
tal of 29 (19.1%) of the Danish patients had TML, and 43 
(40.6%) of the English patients had TML (p < 0.001)  
(Table 1).
Limited TML was more common in the Danish pa­
tients (65.5%) than in the English patients (46.5%); how­
ever, this difference was not statistically significant. 
Haematoxylin bodies were slightly more common 
FIGURE 1
A. A single laminated microlith in a 35­year­old English patient with a 
left­sided classical seminoma. B. Testicular microlithiasis in the form of a 
haematoxylin body of amorphous calcific debris in a 29­year­old English 
patient with a right­sided classical seminoma.
A
B
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among the English than in the Danish patients. Lam in­
ated calcification was more frequently seen in semin­
omas than in non­seminomas. 
Table 2 provides information about associations be­
tween TML and age, histology, tumour size and tumour 
stage. Tumour stage pT1 was found in 20.2% of the TML 
patients from Denmark and in 41.7% of the English TML 
patients (p = 0.207). A tumour size ≥ 30 mm was found 
in 16.8% in the Danish TML patients and in 35.5% in the 
English TML patients (p = 0.03). 
Table 3 is a contingency table with limited and clas­
sic testicular microlithiasis in seminoma and non­semin­
oma from the Danish and English patients. Seminoma 
was strongly associated with limited TML (OR = 5.6; 95% 
CI: 1.05­30.1) in the Danish patients, but this was not the 
case in the English patients (OR = 0.8; 95% CI: 0.23­2.76). 
Most of the Danish patients were White (98.7%), 
and only two patients were of Asian origin (1.3%). The 
two patients of Asian origin had no TML diagnosis.
Among the English patients, a total of 72 (67.9%) 
patients were White (27 with TML and 45 without), two 
(1.9%) Black (one with TML and one without), eight 
(7.5%) Asian (five with TML and three without) and 20 
(22.7%) with no specified ethnicity (nine with TML and 
11 without). 
DISCUSSION
To our knowledge, with 258 histopathological orchiec­
tomy specimens this is the largest study to investigate 
histology TML prevalence in men with testicular cancer 
from two different European countries.  
TML was present in 19% of the Danish population of 
cancer patients, and 41% in the English population of 
cancer patients. Seminoma was statistically associated 
with limited TML in the Danish patients, but not in the 
English patients. This could be caused by the difference 
in tumour size within the two populations, since the size 
of the Danish testicular tumours exceeded the size of 
the English testicular tumours, thus having less sur­
rounding normal tissue to harbour TML. However, other 
studies that have used ultrasonography found the TML 
prevalence in men with testicular cancer to vary from 
15% to 57% [8­11]. 
The two types of TML (haematoxylin body and lam­
in ated calcification) have been related to germ cell tu­
mours [3, 5]. Some studies have suggested that TML 
may have a stronger association with seminoma than 
other subtypes [3, 4]. However, this association was 
seen in men with limited TML in our study.
A Japanese study investigated 200 cancer speci­
mens (56 orchiectomies and 144 biopsies), and found 41 
patients with germ cell tumour, of whom four also had 
TABLE 1
Testicular microlithiasis (TML) characteristics in testis cancer patients from Denmark and England. The values are n (%).
Denmark England
all seminoma non-seminoma all seminoma non-seminoma 
Existence of TML
No 123 (80.9) 80 (80.8) 43 (81.1)   63 (59.4) 36 (83.7) 27 (62.8)
Yes   29 (19.1) 19 (19.2) 10 (18.9)   43 (40.6) 27 (16.3) 16 (37.2)
Total 152 (100.0) 99 (100.0) 53 (100.0) 106 (100.0) 63 (100.0) 43 (100.0)
TML type
Limited TML 19 (65.5) 15 (78.9) 4 (40.0) 20 (46.5) 12 (44.4) 8 (50.0)
Classic TML 10 (34.5)   4 (21.1) 6 (60.0) 23 (53.5) 15 (55.6) 8 (50.0)
Histopathological type
Laminated calcification 12 (41.4) 10 (52.6) 2 (20.0) 11 (25.6) 8 (29.6) 3 (18.8)
Haematoxylin body   6 (20.7)   3 (15.8) 3 (30.0) 15 (34.9) 7 (25.9) 8 (50.0)
Both 11 (37.9)   6 (31.6) 5 (50.0) 17 (39.5) 12 (44.5) 5 (31.2)
TML position
TML in tumour   4 (13.8)   3 (15.8) 1 (10.0)   6 (14.0)   5 (18.5)   1 (6.3)
TML outside tumour 17 (58.6) 13 (68.4) 4 (40.0) 21 (48.8) 10 (37.0) 11 (68.8)
TML both in tumour and outside   8 (27.6)   3 (15.8) 5 (50.0) 14 (32.6) 10 (37.0)   4 (24.9)
TML outside testis   0   0 0   2 (4.6)   2 (7.5)   0
Histopathology slides with TML, n
1­3 25 (86.2) 17 (89.5) 8 (80.0) 29 (59.1) 17 (63.0) 12 (75.0)
4­8   4 (13.8)   2 (10.5) 2 (20.0) 14 (40.9) 10 (37.0)   4 (25.0)
Existence of macro-calcification
No 150 (98.7) 97 (98.0) 53 (100.0) 103 (97.2) 61 (95.1) 0
Yes     2 (1.3)   2 (2.0)   0     3 (2.8)   3 (4.9) 0
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TML (9.8%) [14]. In another study from Japan 41 men 
with unilateral tumours had ultrasonography and biopsy 
performed on the contralateral testis [15]. Eleven of the 
41 patients were diagnosed with TML (26.8%) by ultra­
sonography, but only two patients had the TML diagno­
sis confirmed pathologically. 
Sharmeen et al investigated sonograms of a total of 
346 men with testicular tumours, and found 51% (n = 
175) had one or more microliths, and 20% (n = 69) had 
more than five microliths [3]. This corresponds well with 
our finding that 66% (n = 19) men had limited TML in the 
Danish population, but not in the English population of 
47% (n = 20). In general, limited TML was more common 
than classic TML in both our populations. 
Our findings suggest that TML may not be a pre­
malignant condition. This is supported by the fact that 
only 14% of the patients had TML located inside the tu­
mour tissue, and TML in symptomatic populations is 
high (range: 8.7­18.1%). Instead, it seems that testicular 
cancers coexist with TML. However, the growth of tes­
ticular tumours occurs mostly expansively (and not in­
vasively), which may affect the number of microliths 
placed inside the tumour tissue.    
The strength of this study is the unique opportunity 
afforded to compare two populations with testicular 
cancer from two European countries using one observer. 
The two populations were unequally distributed con­
cerning ethnicity. Testicular cancer is rare in certain 
popu lations, e.g. African and Asian [16, 17]. TML is more 
present in some ethnicity groups than in others [18].  
A recently published study found that Black men from 
southeast London had an increased risk of TML com­
pared to White men, and that the most deprived socio­
economic groups had an increased risk of developing 
TML [19]. In this study of testicular cancer patients from 
southeast London, we found no differences in the preva­
lence of TML between different ethnic groups. All these 
observations combined suggest that there is no associ­
ation between TML and testicular cancer. 
When producing the histopathology slides, it is pos­
sible that the microliths could have been lost when pro­
cessing the samples, resulting in the TML count being 
falsely low. In general, the tumour specimens contained 
a total of eight slides, but the very large tumours had 
more slides and this could affect the total count of  
microliths. 
Histologically, it is expected that 60% of the testi­
cular germ cell tumours are seminoma and 40% non­
seminoma [20]. We found that a total of 99 out of 152 
(65%) of the Danish men were diagnosed with semino­
ma. The corresponding figures for English men were 63 
out of 106 (59%). 
The prevalence of TML was not similar in the two 
populations, but this variation is not unusual. A Japanese 
study evaluated pathologic specimens from 56 orchiec­
tomies and 144 testicular biopsies, and found TML in 
7.1% of the orchiectomies and 2.1% of the biopsies [14]. 
TABLE 3
Limited (1-4 microliths) or classic (≥ 5 microliths) testicular microlithiasis associated with cancer type in Denmark and England.
Denmark England
limited TML, n classic TML, n total, n OR (95% CI) limited TML, n classic TML, n total, n OR (95% CI)
Seminoma 15   4 19 ­ 12 15 27 ­
Non­seminoma   4   6 10 ­   8   8 16 ­
Total 19 10 29 5.6 (1.05­30.1) 20 23 43 0.8 (0.23­2.76)
CI = confidence interval; OR = odds ratio; TML = testicular microlithiasis.
TABLE 2
Association between the Danish and English cancer patients.
Denmark England
TML,  
n (%)
(N = 29) 
No TML,  
n (%)
(N = 123) OR (95% CI)a
TML,  
n (%)
(N = 43)
No TML, 
n (%)
(N = 63) OR (95% CI)a
Histology
Seminoma 19 (19.2) 80 (80.8) 1.00 (ref.) 27 (42.9) 36 (57.2) 1.00 (ref.)
Non­
semin oma
10 (18.9) 43 (81.1) 0.73 (0.28­1.03) 16 (37.2) 27 (62.8) 0.79 (0.35­1.77)
Side
Left 14 (18.9) 60 (81.1) 1.05 (0.46­2.37) 19 (38.8) 30 (61.2) 1.14 (0.52­2.51)
Right 15 (19.2) 63 (80.8) 1.00 (ref.) 24 (42.1) 33 (57.9) 1.00 (ref.)
Stage
pT1 26 (20.2) 103 (79.8) 1.00 (ref.) 25 (41.7) 35 (58.3) 1.00 (ref.)
pT2   3 (16.7)   15 (83.3) ­   6 (42.9)   8 (57.1) 1.22 (0.36­4.11)
pT3   0     5 (100) 3.12 (0.65­15.07) 12 (38.7) 19 (61.3) 0.89 (0.36­2.17)
Not known   0     0 ­   0   1 (100) ­
Tumour size
< 30 mm 12 (22.6) 41 (77.4) 1.26 (0.52­3.03) 21 (47.7) 23 (52.3) 1.77 (0.79­3.96)
≥ 30 mm 16 (16.8) 79 (83.2) 1.00 (ref.) 22 (35.5) 40 (64.5) 1.00 (ref.)
Unknown   1 (25.0)   3 (75.0) 1.06 (0.11­10.27) ­ ­ ­
Age
< 40 yrs 19 (20.2) 75 (79.8) 1.00 (ref.) 27 (38.6) 43 (61.4) 1.00 (ref.)
≥ 40 yrs 10 (17.2) 48 (82.8) 2.40 (0.57­10.16) 16 (44.4) 20 (55.6) 0.85 (0.23­3.05)
CI = confidence interval; OR = odds ratio; TML = testicular microlithiasis.
a) OR analysis adjusted for age and year of diagnosis.
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Renshaw investigated 79 orchiectomy specimens with 
germ cell tumour, and TML were present in 38 (48.1%) 
[5]. There seems to be a large variation between popula­
tions. 
CONCLUSIONS
The English testicular cancer patients had a statistically 
significantly higher TML prevalence than the Danish pa­
tients. This observation may question the suggested  
hypothesised biological association between TML and 
testicular cancer. However, other risk factors have not 
been investigated. 
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